title: Pertussis, a disease whose time has come: what can be done to control the problem?
abstract: In the United States, major epidemics of pertussis or whooping cough have occurred in the last 5 years making this disease a major public health issue. The adolescent and adult populations are the major transmitters of disease to the community. However, these epidemics have had the greatest effect on the young infant population resulting in high rates of hospitalizations and complications and accounting for 100% of the mortality. Optimization of vaccine recommendations is a strategy that is critically important as a method to control the disease burden and decrease the transmission of disease to the young infant population. Immunization that is focused on the close contacts of these young infants (the cocoon strategy) is felt to be one of the main cornerstones to vaccine optimization with the immunization of pregnant women being critical. Transmission studies have shown that adolescent and adult close contacts, especially new mothers, are the source of disease transmission to their young infants in more than 50% of the cases. The Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists strongly recommend that the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis booster vaccine be given to pregnant women during each pregnancy between 27 weeks and 36 weeks of gestation to protect their infant against pertussis disease.
authors: Departments of Pediatrics and Obstetrics and Gynecology, Northwestern University's Feinberg School of Medicine, and the Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
authors: Tina Q
authors: TQ
authors: Tan
authors: Melvin V
authors: MV
authors: Gerbie
mesh_terms: D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007223:Infant; D032541:Mass Vaccination; D011247:Pregnancy; D014917:Whooping Cough / Q000517:prevention & control*
chemical_list: D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines
references: Guris D, Stebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, et al.. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999;28:1230–7.
references: Centers for Disease Control and Prevention. Pertussis—United States, 1997-2000. MMWR Morb Mortal Wkly Rep 2002;51:73–6.
references: Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, et al.. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007;26:293–9.
references: Kretsinger K, Broder KR, Coretese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al.. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among healthcare personnel. MMWR Recomm Rep 2006;55:1–37.
references: Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, et al.. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants. Recommendations of the Advisory Committee on Immunization Practices (ACIP) [published erratum appears in MMWR Morb Mortal Wkly Rep 2008;57:723]. MMWR Recomm Rep 2008;57:1–51.
references: Centers for Disease Control and Prevention (CDC). Updated recommendations for Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months—Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1424–6.
references: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Committee Opinion No. 566. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013;121:1114–4.
references: Halperin BA, Morris A, MacKinnon-Cameron D, Mutch J, Langley JM, McNeil SA, et al.. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis 2011;53:885–92.